Ovulatory and Reproductive Characteristics of Sows Treated with an Intravaginal GNRH Agonist Gel
| dc.contributor.advisor | Glen Almond, Committee Member | en_US |
| dc.contributor.advisor | Scott Whisnant, Committee Member | en_US |
| dc.contributor.advisor | William Flowers, Committee Chair | en_US |
| dc.contributor.advisor | Mitchell Hockett, Committee Member | en_US |
| dc.contributor.author | Roski, Kara Howes | en_US |
| dc.date.accessioned | 2010-04-02T17:56:46Z | |
| dc.date.available | 2010-04-02T17:56:46Z | |
| dc.date.issued | 2005-03-01 | en_US |
| dc.degree.discipline | Animal Science | en_US |
| dc.degree.level | thesis | en_US |
| dc.degree.name | MS | en_US |
| dc.description.abstract | This study was designed to test the reproductive and ovulatory characteristics of sows treated with Ovugel® (EIEICO, Radnor, PA), a gel containing a GnRH agonist (Triptorelin) administered intravaginally. The treatment groups received 100μg of GnRH agonist intravaginally in varying viscosities of the gel, .6%(n=12), .9%(n=12), 1.2%(n=12), and 1.5%(n=12) respectively. A positive control group (n=11) received saline containing 100μg of GnRH agonist while the control sows (n=12) received a vehicle of the 1.2% gel and at 96h post weaning. Jugular cannulas were placed 48 hours before administration of the treatment. Blood samples were taken every 6 hours before treatment, then every 2 hours for the first 12 hours after treatment, then every 6 hours for the next 18 hours. Estrus detection occurred every 6 hours through the entire study. Real time ultrasonography was conducted every 4 hours to determine the time of ovulation. Control sows were bred based on the onset of estrus and treatment sows were bred at +8 and +32 h after the gel was administered. All data was analyzed using SAS and the proc GLM procedure. Treatment Saline + GnRH Control 0.6% + GnRH 0.9% + GnRh 1.2% + GnRH 1.5% + GnRH Ovulation time (h) 46.5±1.2 43.8±5.4 43.8±2.0 41.2±3.3 43.5±1.8 44.5±1.5 Estrus length (h) 45.8±3.4 45.6±3.8 49.0±3.8 47±3.2 46.9±3.9 55.1±3.9 LH surge (0-30h post treatment) 7/10 5/8 7/10 9/11 8/10 8/9 Farrowing Rate 8/8 9/9 11/12 10/12 11/12 10/11 Litter Size 12.9±0.7 9±3.1.2 11±1.3 11.6±1.0 11±0.5 10.6±1.4 There were no differences in treatments in ovulation time from the onset of estrus or administration of Ovugel® (p=0.28), estrus length (p=.60), farrowing rate (p=0.80), litter size (p=0.35), or LH surge (p=0.49). However, variation associated with ovulation time was significantly reduced (p=0.01) for saline, 1.2%, and 1.5% treatments compared with controls. The duration of estrus was greater for the 1.5% gel with the triptorelin than the sows receiving only the 1.2% gel (p=0.04). The intravaginal absorption of GnRH in Ovugel® or saline along with a timed insemination program is an effective method to reduce the interval over which ovulation occurs without overtly decreasing fertility. KEY WORDS: ovulation, GnRH agonist, swine | en_US |
| dc.identifier.other | etd-11172004-141537 | en_US |
| dc.identifier.uri | http://www.lib.ncsu.edu/resolver/1840.16/561 | |
| dc.rights | I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to NC State University or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report. | en_US |
| dc.subject | swine | en_US |
| dc.subject | ovulation | en_US |
| dc.subject | GNRH agonist | en_US |
| dc.title | Ovulatory and Reproductive Characteristics of Sows Treated with an Intravaginal GNRH Agonist Gel | en_US |
Files
Original bundle
1 - 1 of 1
